Waiting in anticipation: The genetics of pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 9, 2012, Pages 820-821

  Aldred, Micheala A ^a   Morrell, Nicholas W ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

AUTOSOMAL DOMINANT DISORDER; EDITORIAL; FRAMESHIFT MUTATION; GENETIC DAMAGE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RECEPTOR GENE; SOMATIC MUTATION; TANDEM REPEAT; VARIABLE NUMBER OF TANDEM REPEAT;

ANTICIPATION, GENETIC; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE;

EID: 84868298212     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201209-1666ED     Document Type: Editorial

References (15)

1. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;69:385.
2. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, Reardon W, Fenton I, Shaw DJ, Harper PS. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-1174.
3. Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA III, Newman JH. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 1995;152:93-97.
4. Loyd JE, Slovis B, Phillips JA III, Butler MG, Foroud TM, Conneally PM, Newman JH. The presence of genetic anticipation suggests that the molecular basis of familial primary pulmonary hypertension may be trinucleotide repeat expansion. Chest 1997;111:82S-83S.
5. Lane KB, Machado RD, Pauciulo M, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC; The International PPH Consortium. Het-erozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84.
6. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morpho-genetic protein receptor-II gene. Am J Hum Genet 2000;67:737-744.
7. Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA III, Hamid R, Loyd JE. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmo-nary arterial hypertension. Am J Respir Crit Care Med 2012;186:892-896.
8. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101:927-934.
9. Humbert M, Hoeper MM. Severe pulmonary arterial hypertension: a forme fruste of cancer? Am J Respir Crit Care Med 2008;178:551-552.
10. Rai PR, Cool CD, King JA, Stevens T, Burns N, Winn RA, Kasper M, Voelkel NF. The cancer paradigm of severe pulmonary arterial hy-pertension. Am J Respir Crit Care Med 2008;178:558-564.
11. Machado RD, James V, Southwood M, Harrison RE, Atkinson C, Stewart S, Morrell NW, Trembath RC, Aldred MA. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation 2005;111:607-613.
12. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Micro-satellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001;88:E2-E11.
13. Aldred MA, Comhair SA, Varella-Garcia M, Asosingh K, Xu W, Noon GP, Thistlethwaite PA, Tuder RM, Erzurum SC, Geraci MW, et al. Somatic chromosome abnormalities in the lungs of patients with pulmonary ar-terial hypertension. Am J Respir Crit Care Med 2010;182:1153-1160.
14. Humbert M, Deng Z, Simonneau G, Barst RJ, Sitbon O, Wolf M, Cuervo N, Moore KJ, Hodge SE, Knowles JA, et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 2002;20:518-523.
15. Hamid R, Cogan JD, Hedges LK, Austin E, Phillips JA III, Newman JH, Loyd JE. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hum Mutat 2009;30:649-654.